ArticleFrontiers in immunology2025
Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients.
Iván Ferraz-Amaro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it